Progress in the prevention and treatment of RSV infection
- PMID: 25140965
- DOI: 10.1056/NEJMe1407467
Progress in the prevention and treatment of RSV infection
Comment on
-
Oral GS-5806 activity in a respiratory syncytial virus challenge study.N Engl J Med. 2014 Aug 21;371(8):711-22. doi: 10.1056/NEJMoa1401184. N Engl J Med. 2014. PMID: 25140957 Clinical Trial.
Similar articles
-
Chemotherapy of respiratory syncytial virus infections: the final breakthrough.Int J Antimicrob Agents. 2015 Mar;45(3):234-7. doi: 10.1016/j.ijantimicag.2014.12.025. Epub 2015 Feb 2. Int J Antimicrob Agents. 2015. PMID: 25684638 Review.
-
Oral GS-5806 activity in a respiratory syncytial virus challenge study.N Engl J Med. 2014 Aug 21;371(8):711-22. doi: 10.1056/NEJMoa1401184. N Engl J Med. 2014. PMID: 25140957 Clinical Trial.
-
New options in the treatment of respiratory syncytial virus disease.J Infect. 2015 Jun;71 Suppl 1:S80-7. doi: 10.1016/j.jinf.2015.04.025. Epub 2015 Apr 25. J Infect. 2015. PMID: 25922289 Review.
-
Preventive and therapeutic strategies for respiratory syncytial virus infection.Curr Opin Pharmacol. 2001 Oct;1(5):497-503. doi: 10.1016/s1471-4892(01)00087-x. Curr Opin Pharmacol. 2001. PMID: 11764776 Review.
-
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.Expert Opin Investig Drugs. 2000 Feb;9(2):221-35. doi: 10.1517/13543784.9.2.221. Expert Opin Investig Drugs. 2000. PMID: 11060673 Review.
Cited by
-
Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses.PPAR Res. 2021 Oct 27;2021:6741290. doi: 10.1155/2021/6741290. eCollection 2021. PPAR Res. 2021. PMID: 34721558 Free PMC article. Review.
-
A COVID-19 human viral challenge model. Learning from experience.Influenza Other Respir Viruses. 2020 Nov;14(6):747-756. doi: 10.1111/irv.12797. Epub 2020 Aug 12. Influenza Other Respir Viruses. 2020. PMID: 32790065 Free PMC article. Review.
-
The Impact of RSV-Associated Respiratory Disease on Children in Asia.J Pediatr Infect Dis. 2019 Apr;14(3):79-88. doi: 10.1055/s-0038-1637752. Epub 2018 Apr 11. J Pediatr Infect Dis. 2019. PMID: 32300274 Free PMC article. Review.
-
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.Viruses. 2018 Jan 21;10(1):48. doi: 10.3390/v10010048. Viruses. 2018. PMID: 29361733 Free PMC article. Review.
-
Respiratory syncytial virus infection in older adults: an under-recognized problem.Drugs Aging. 2015 Apr;32(4):261-9. doi: 10.1007/s40266-015-0258-9. Drugs Aging. 2015. PMID: 25851217
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical